We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
South Carolina is suing five pharmaceutical companies for $40 million, alleging the firms overcharged the state for prescription drugs financed through Medicaid and the State Health Plan of South Carolina.
Wolf Popper LLP has filed a securities fraud lawsuit in the United States District Court for the District of New Jersey on behalf of all persons who purchased the securities of Par Pharmaceutical Companies, Inc. ("Par" or the "Company") between April 29, 2004 and July 5, 2006, inclusive (the "Class Period").
Wyeth announced that the company has designated both Triphasil-28 (levonorgestrel and ethinyl estradiol tablets-triphasic regimen) and Alesse (0.1 mg levonorgestrel/0.02 mg ethinyl estradiol tablets) oral contraceptives as temporarily out of stock (TOS).
A federal appeals court dealt Pfizer Inc. a legal setback Wednesday when it issued a ruling that threatens to cut 15 months from the patent life of its popular cholesterol drug Lipitor, the world's biggest-selling medicine.
The FDA has approved Enzon Pharmaceuticals' supplemental biologics license application for its acute lymphoblastic leukemia (ALL) drug Oncaspar, the agency said.
A key lawmaker in the fight over Andrew von Eschenbach's nomination as FDA commissioner is questioning the agency's Plan B enforcement plan as "unprecedented" and possibly a ploy to prevent OTC sale of the drug.